The German firm’s holding moves up from 49%, as it eyes a firm foothold in “one of the key growth markets in Asia.” By the end of next year, however, Stada plans to divest its stake in another of its joint ventures in the country.
Stada Arzneimittel has “an excellent basis for becoming a key leader in Vietnam,” after officially increasing its holding to 72% in Tuy Hòa-based player Pymepharco, the second-largest generics manufacturer in the country.
In October, Pymepharco’s board of directors approved plans to allow foreign companies to own a 100% share of the company,...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
